Healthcare & Life Sciences

Tactiva Therapeutics

Tactiva Therapeutics is a startup based in the United States.

About Tactiva Therapeutics

Tactiva Therapeutics is a company headquartered in the United States.

Tactiva Therapeutics develops next-generation adaptive cell therapies (ACT) using a T-cell receptor (TCR) approach that combines CD4 and CD8 systems. Its autologous DEACT program targets NY-ESO-1 in ovarian and other solid tumors and has received IND clearance in the US.

Explore Tactiva Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States